JAMA Oncology : Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
- Author
- American Medical Association, 2017
- Published
- Thu 30 Jan 2025
- Episode Link
- https://edhub.ama-assn.org/jn-learning/audio-player/10.1001/jamaoncol.2024.6669
Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.
Related Content:
